Healionics Raises $4.7M Equity Round to Support Commercialization of STARgraft Vascular Graft
Healionics is preparing to commercialize its innovative STARgraft vascular graft, designed to provide a safer and more reliable means to access the bloodstream for dialysis in patients with kidney failure.